Compass Therapeutics
Home
About
Platform
Pipeline
Clinical Trials
Join Us
Investors
Contact
Compass Therapeutics raises $130 million to develop I-O candidate
Compass Therapeutics raises $130 million to develop I-O candidate
Post navigation
Previous Post
Previous
Compass Therapeutics eyes possible IPO after $132M investment
Next Post
Next
FierceBiotech’s 2018 Fierce 15
Home
About
Platform
Pipeline
Clinical Trials
Join Us
Investors
Contact